NorthWest Biotherapeutics Inc (NWBO)

[Adam_Feuerstein]

Chris, I thought you were bullish on NWBO?

If NWBO announces the passing of 248 PFS events in the phase III study without disclosing the outcome, the study failed.

PFS is the primary endpoint of the phase 3 study. When the primary endpoint fails, there is no valid statistical test for secondary endpoints. NWBO cannot fail on PFS and succeed on OS in the phase III study. Any claim otherwise will be laughed out of the FDA.

Now, given Linda's history of misleading statements about DCVax and the phase 3 study, I'm sure she'll try to pull of another stunt. That will fun to watch.

Maybe the games are just getting started. I hope so. There's no fun like writing about NWBO fun.